Rheumatic Mitral Valve Diseases Treatment Market Growth Trajectory by 2034
The Rheumatic Mitral Valve Diseases Treatment Market was valued at USD 3.1 billion in 2024 which is projected to reach USD 5.2 billion by the end of 2034 , growing a strong CAGR of 7% from 2025-2034. This growth is attributed to the increasing global burden of rheumatic heart disease (RHD), ongoing innovations in surgical and catheter-based interventions, and a growing elderly population, especially in low- and middle-income countries where rheumatic fever remains prevalent. Rheumatic Mitral Valve Diseases Treatment Industry Demand The Rheumatic Mitral Valve Diseases Treatment Market focuses on therapies and procedures aimed at managing complications arising from rheumatic fever that lead to mitral valve stenosis or regurgitation. Rheumatic mitral valve disease is a significant public health issue, particularly in developing regions, and often requires long-term pharmacological management or surgical intervention. Industry demand is driven by the increasing prevalence ...